The researchers note that patients taking other types of HIV medications did not show the same reduction ... iVeena Delivery ...

A new study has found that a common class of medications could dramatically decrease the risk of developing the neurodegenerative disorder.

Now, researchers from UVA Health have uncovered a promising link between drugs initially developed for HIV and reduced Alzheimer's risk, highlighting an unexpected pathway for potential prevention.

The drugs, called NRTIs, have the potential to prevent a million cases of Alzheimer's every year, the researchers believe.

UVA Health scientists are calling for clinical trials testing the potential of HIV drugs called NRTIs to prevent Alzheimer’s disease after discovering that patients taking the drugs are substantially ...

As the Trump administration slashes funding for HIV-related research and infrastructure, Gilead, Immunocore and more are ...

UVA scientists are calling for clinical trials to see if common HIV drugs could prevent up to 1 million new Alzheimer’s cases ...

This marks a shift in the agency's approach to treating the global obesity problem. Read more at straitstimes.com. Read more ...

People taking drugs for HIV and hepatitis B are less likely to develop Alzheimer’s disease, according to a new study. UVA ...

Get Instant Summarized Text (Gist) Analysis of large health databases indicates that patients taking nucleoside reverse transcriptase inhibitors (NRTIs), drugs used for HIV and hepatitis B, have a ...

The researchers note that patients taking other types of HIV medications did not show the ... Systems and Inflammasome Therapeutics; a full list of the authors’ disclosures is included in ...